211 related articles for article (PubMed ID: 17362404)
1. Model averaging using fractional polynomials to estimate a safe level of exposure.
Faes C; Aerts M; Geys H; Molenberghs G
Risk Anal; 2007 Feb; 27(1):111-23. PubMed ID: 17362404
[TBL] [Abstract][Full Text] [Related]
2. A probabilistic framework for non-cancer risk assessment.
Chen JJ; Moon H; Kodell RL
Regul Toxicol Pharmacol; 2007 Jun; 48(1):45-50. PubMed ID: 17166641
[TBL] [Abstract][Full Text] [Related]
3. Bootstrap estimation of benchmark doses and confidence limits with clustered quantal data.
Zhu Y; Wang T; Jelsovsky JZ
Risk Anal; 2007 Apr; 27(2):447-65. PubMed ID: 17511711
[TBL] [Abstract][Full Text] [Related]
4. Model averaging in microbial risk assessment using fractional polynomials.
Namata H; Aerts M; Faes C; Teunis P
Risk Anal; 2008 Aug; 28(4):891-905. PubMed ID: 18564995
[TBL] [Abstract][Full Text] [Related]
5. The benchmark dose method--review of available models, and recommendations for application in health risk assessment.
Filipsson AF; Sand S; Nilsson J; Victorin K
Crit Rev Toxicol; 2003; 33(5):505-42. PubMed ID: 14594105
[TBL] [Abstract][Full Text] [Related]
6. Model uncertainty and risk estimation for experimental studies of quantal responses.
Bailer AJ; Noble RB; Wheeler MW
Risk Anal; 2005 Apr; 25(2):291-9. PubMed ID: 15876205
[TBL] [Abstract][Full Text] [Related]
7. Effects of exposure imprecision on estimation of the benchmark dose.
Budtz-Jørgensen E; Keiding N; Grandjean P
Risk Anal; 2004 Dec; 24(6):1689-96. PubMed ID: 15660622
[TBL] [Abstract][Full Text] [Related]
8. A procedure for developing risk-based reference doses.
Gaylor DW; Kodell RL
Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):137-41. PubMed ID: 12051999
[TBL] [Abstract][Full Text] [Related]
9. Comparing experimental designs for benchmark dose calculations for continuous endpoints.
Kuljus K; von Rosen D; Sand S; Victorin K
Risk Anal; 2006 Aug; 26(4):1031-43. PubMed ID: 16948695
[TBL] [Abstract][Full Text] [Related]
10. [Quantitative methods of cancer risk assessment in exposure to chemicals].
Szymczak W
Med Pr; 2009; 60(3):215-21. PubMed ID: 19746890
[TBL] [Abstract][Full Text] [Related]
11. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
Müller L; Gocke E; Lavé T; Pfister T
Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
[TBL] [Abstract][Full Text] [Related]
12. Properties of model-averaged BMDLs: a study of model averaging in dichotomous response risk estimation.
Wheeler MW; Bailer AJ
Risk Anal; 2007 Jun; 27(3):659-70. PubMed ID: 17640214
[TBL] [Abstract][Full Text] [Related]
13. Monotonic Bayesian semiparametric benchmark dose analysis.
Wheeler M; Bailer AJ
Risk Anal; 2012 Jul; 32(7):1207-18. PubMed ID: 22385024
[TBL] [Abstract][Full Text] [Related]
14. Precision of benchmark dose estimates for continuous (nonquantal) measurements of toxic effects.
Gaylor DW; Chen JJ
Regul Toxicol Pharmacol; 1996 Aug; 24(1 Pt 1):19-23. PubMed ID: 8921542
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent number of implants and implications in developmental toxicity.
Dunson DB
Biometrics; 1998 Jun; 54(2):558-69. PubMed ID: 9629644
[TBL] [Abstract][Full Text] [Related]
16. [Application of BMD models in quantitative evaluation of carcinogenic risk].
Szymczak W
Med Pr; 1998; 49(6):579-87. PubMed ID: 10204147
[TBL] [Abstract][Full Text] [Related]
17. EMS in Viracept--initial ('traditional') assessment of risk to patients based on linear dose response relations.
Gocke E; Müller L; Pfister T
Toxicol Lett; 2009 Nov; 190(3):266-70. PubMed ID: 19439165
[TBL] [Abstract][Full Text] [Related]
18. Stability of multivariable fractional polynomial models with selection of variables and transformations: a bootstrap investigation.
Royston P; Sauerbrei W
Stat Med; 2003 Feb; 22(4):639-59. PubMed ID: 12590419
[TBL] [Abstract][Full Text] [Related]
19. Identification of a critical dose level for risk assessment: developments in benchmark dose analysis of continuous endpoints.
Sand S; von Rosen D; Victorin K; Filipsson AF
Toxicol Sci; 2006 Mar; 90(1):241-51. PubMed ID: 16322076
[TBL] [Abstract][Full Text] [Related]
20. A parametric model for detecting hormetic effects in developmental toxicity studies.
Hunt DL; Bowman D
Risk Anal; 2004 Feb; 24(1):65-72. PubMed ID: 15028001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]